Fat $34M Series A Launches Start-Up Obesity Firm Ember
BioWorld Today Contributing Writer
Third Rock Ventures LLC said today the newest member of its portfolio, Ember Therapeutics, launched with a $34 million Series A financing. Ember will focus on discovery and development of obesity and diabetes therapeutics based on brown fat biology and new science relating to insulin sensitivity.
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST